Key Takeaway
What is the average weight loss on liraglutide 1.8mg? Review clinical trial data from LEAD and SCALE studies, realistic expectations, and factors that affect results.
The average weight loss on liraglutide 1.8mg ranges from about 4% to 6% of body weight based on clinical trial data, though individual results vary widely. If your physician has prescribed liraglutide at this dose, understanding realistic expectations can help you stay on track and make informed decisions about your treatment.
Clinical Trial Results at 1.8mg
Liraglutide 1.8mg is the maximum approved dose under the Victoza label for type 2 diabetes. While Victoza was not specifically approved for weight loss, the LEAD trial program documented weight changes as a secondary outcome. Here is what those trials found:
| Trial | Duration | Mean Weight Change | Comparator |
|---|---|---|---|
| LEAD-1 | 26 weeks | -1.0 kg vs. baseline | Glimepiride added weight (+0.1 kg) |
| LEAD-2 | 26 weeks | -2.8 kg | Glimepiride added (+1.0 kg) |
| LEAD-3 | 52 weeks | -2.5 kg | Glimepiride added (+1.1 kg) |
| LEAD-5 | 26 weeks | -3.4 kg | Insulin glargine added (+1.8 kg) |
| LEAD-6 | 26 weeks | -3.2 kg | Exenatide 10mcg (-2.9 kg) |
These numbers may look modest compared to what you see reported for higher-dose GLP-1 therapies. Keep in mind that the LEAD participants were managing type 2 diabetes, not specifically seeking weight loss. Their baseline BMI, concomitant medications, and study goals were different from dedicated weight-management trials.
How 1.8mg Compares to Other Liraglutide Doses
Weight loss with liraglutide is dose-dependent. In the SCALE Obesity[1] and Prediabetes trial, the 3.0mg daily dose produced an average weight loss of 8.0% of body weight over 56 weeks, compared to 2.6% for placebo.
View data table
| Category | Mean Body Weight Loss (%) | Detail |
|---|---|---|
| Tirzepatide | 22 | ~22% body weight at 72 wks |
| Semaglutide | 15 | ~15% body weight at 68 wks |
| Liraglutide | 8 | ~8% body weight at 56 wks |
| Retatrutide | 24 | ~24% in Phase 2 trial |
A dose-ranging study published in The Lancet showed a clear gradient:
- 1.2mg daily: approximately 4.8 kg lost over 20 weeks
- 1.8mg daily: approximately 5.5 kg lost over 20 weeks
- 2.4mg daily: approximately 6.3 kg lost over 20 weeks
- 3.0mg daily: approximately 7.2 kg lost over 20 weeks
This means liraglutide 1.8mg delivers roughly 70 to 75% of the weight loss seen at the full 3.0mg dose. For patients who tolerate 1.8mg well but struggle with side effects at higher doses, this can be a practical long-term option.
What Affects Your Individual Results
Averages from clinical trials are useful benchmarks, but your personal experience may differ. Several factors play a role:
Check your GLP-1 eligibility
Use our free BMI Calculator to see if you may qualify for provider-reviewed GLP-1 therapy.
Try the BMI Calculator →- Starting weight: Patients with higher baseline BMI often see larger absolute weight loss in kilograms, though the percentage may be similar.
- Diet quality: Liraglutide reduces appetite, but it works best when paired with a balanced, calorie-appropriate eating plan. Patients who make deliberate dietary changes tend to lose more. diet tips while on GLP-1 medications
- Physical activity: Regular exercise amplifies weight loss and helps preserve lean muscle mass during treatment.
- Metabolic health: Insulin resistance, thyroid function, and other metabolic factors influence the pace and extent of weight loss.
- Medication adherence: Liraglutide requires daily injections. Missing doses reduces drug exposure and can slow progress.
- Concomitant medications: Some drugs (beta-blockers, certain antidepressants, insulin) can promote weight gain, partially offsetting the effects of liraglutide.
Setting Realistic Expectations Month by Month
If you're using liraglutide 1.8mg primarily for weight management (whether as your target dose or a step in the titration), here is a general timeline:
| Timeframe | What to Expect |
|---|---|
| Weeks 1 to 4 | 1 to 3 lbs. Appetite changes begin. Some patients notice reduced cravings before the scale moves. |
| Months 1 to 3 | 3 to 8 lbs typical. Steady, modest decline. Most noticeable when combined with dietary adjustments. |
| Months 3 to 6 | 5 to 12 lbs cumulative for good responders. Weight loss pace may slow as body adapts. |
| Months 6 to 12 | Plateau zone for many patients at this dose. Physician may consider increasing to 2.4mg or 3.0mg. |
When to Discuss Moving to a Higher Dose
The Saxenda prescribing information recommends evaluating weight loss at 12 weeks on the maintenance dose (3.0mg). If a patient hasn't lost at least 4% of baseline body weight by that point, discontinuation should be considered.
A similar principle can guide decisions at 1.8mg. If you have been at this dose for 8 to 12 weeks and haven't seen meaningful progress, your physician may recommend advancing to 2.4mg and eventually 3.0mg, or exploring alternative medications. liraglutide titration schedule
Frequently Asked Questions
Is 5 to 6% body weight loss meaningful?
Yes. A 5% reduction in body weight has been shown to improve blood pressure, cholesterol levels, blood sugar control, and reduce the risk of developing type 2 diabetes. Clinical guidelines consider 5% a clinically significant threshold.
Will I lose more weight if I increase to 3.0mg?
On average, yes. The dose-response relationship with liraglutide is well established. The jump from 1.8mg to 3.0mg typically adds another 2 to 3 percentage points of body weight loss. But side effects also tend to increase, so the decision involves balancing efficacy and tolerability. liraglutide 3.0mg weight loss average
How does liraglutide 1.8mg compare to semaglutide for weight loss?
Semaglutide at its approved weight loss dose (2.4mg weekly) produces significantly greater weight loss than liraglutide 1.8mg daily. The STEP 1 trial[2] reported approximately 14.9% body weight[2] loss with semaglutide 2.4mg, compared to the 4 to 6% range typically seen with liraglutide 1.8mg. Your physician will help determine which medication best fits your health profile.
Can I keep losing weight at 1.8mg long-term?
Most patients reach a weight plateau within 6 to 12 months at any given dose. Continued weight loss after that typically requires dose adjustment, dietary changes, or increased physical activity. Maintaining the weight you have already lost is also a valid and important goal.
Medical References
- Pi-Sunyer X, Astrup A, Fujioka K, et al. A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. N Engl J Med. 2015;373(1):11-22. [PubMed | ClinicalTrials.gov | DOI]
- Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021;384(11):989-1002. [PubMed | ClinicalTrials.gov | DOI]
Get Personalized Weight Loss Guidance
At FormBlends, our physicians review your health history, lab work, and goals to recommend the right dose and timeline for your situation. If you're seeing results at 1.8mg or wondering if it's time to adjust, we're here to help you manage the process.
Want to know if your current dose is working for you? Schedule a consultation with a FormBlends physician today.
Talk to a licensed provider
Start your free assessment. A licensed provider reviews every request before anything is prescribed, and not everyone qualifies.
Start the assessment →